Related Experiment Videos
[Cardiac resynchronization therapy-current status and future perspectives].
Christoph Stellbrink1, Ole-Alexander Breithardt
1Medizinische Klinik I, Rheinisch-Westfälische Technische Hochschule, Aachen. cstellbrink@ukaachen.de
Herz
|December 23, 2003
Summary
Cardiac resynchronization therapy (CRT) improves heart failure outcomes, reducing mortality and hospitalizations. Future research needs to identify non-responders for better patient selection.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Cardiac resynchronization therapy (CRT) is a novel treatment for advanced heart failure.
- CRT corrects conduction disturbances linked to left ventricular dysfunction, mitigating negative hemodynamic effects.
Purpose of the Study:
- To review the current indications and clinical outcomes of CRT.
- To discuss unresolved issues and future developments in CRT.
Main Methods:
- Review of existing studies and clinical trials on CRT.
- Analysis of current guidelines and patient response data.
Main Results:
- CRT improves cardiac hemodynamics and long-term exercise capacity.
- Significant reductions in mortality, hospitalizations, mitral regurgitation, and left ventricular remodeling are observed.
- Current criteria identify responders, but 30% show no improvement.
Conclusions:
- CRT is indicated for heart failure adjunct treatment, improving outcomes.
- Further research is needed to identify CRT responders and optimize therapy.
- The necessity of defibrillator backup in CRT patients requires further investigation.